Fligstein, Neil (2001) The Architecture of Markets: An Economic Sociology of
Twenty-First-Century Capitalist Societies. NJ: Princeton University Press.
Foucault, Michel (1975) Surveiller et Punir. Naissance de la Prison. Paris: Gallimard.
—— (1988) Technology of the Self. Pp.16-49 in Technologies of the Self: A Seminar with Michel Foucault, edited by Luther H. Martin, Huck Gutman, and Patrick H. Hutton.
London: Tavistock.
—— (1994) Histoire de la Sexualité I : la Volonté de Savoir. Paris: Gallimard.
—— (1997) Il Faut Défendre la Société. Cours au Collège de France. 1976. Paris:
Gallimard.
—— (2004a) Sécurité, Territoire, Population. Cours au Collège de France. 1977-1978.
Paris: Gallimard.
—— (2004b) Naissance de la Biopolitique. Cours au Collège de France. 1978-1979.
Paris: Gallimard.
Fritzell, Bernard (2002) Detection of adverse events: what are the current sensitivity limits during clinical development? Vaccine 20: S47-S48.
Frost and Sullivan (2006) Global Vaccines Markets. Frost & Sullivan.
Fullagar, Simone (2003) Wasted Lives: The Social Dynamics of Shame and Youth
Suicide. Journal of Sociology 39(3): 291-307.
Galambos, Louis and Jane E. Sewell (1995) Networks of Innovation: Vaccine
Development at Merck, Sharp and Dohme & Mulford, 1895-1995. Cambridge:
Cambridge University Press.
—— (1997) Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895-1995 (2nd ed). Cambridge: Cambridge University Press.
Garcia-Parpet, Marie-France (2007 [1986]) The Social Construction of a Perfect Market:
The Strawberry Auction at Fontaines-en-Sologne. Pp. 20-53 in Do Economists
Make Markets? On the Performativity of Economics, edited by Donald MacKenzie,
Fabian Muniesa and Lucia Siu. Princeton: Princeton University Press.Gaudelus, Joël, Robert Cohen and J. Hovart (2007) Couverture vaccinale du vaccine pneumococcique heptavalent conjugé en 2007, comparaison avec les années précédentes et les autres vaccins pédiatriques : analyse des carnets de santé. Médecine & enfance juin 2007: 307-310.
Genel, Katia (2006) The Question of Biopower: Foucault and Agamben. Rethinking
Marxism 18(1): 43-62.
Giebink, G. Scott (2001) The prevention of pneumococcal disease in children. New
England Journal of Medicine 345: 1177-1183.
Glass, R. I. et al. (2005) Rotavirus vaccines: past, present, future. Archives de pédiatrie 12: 844-847.
Gordon, Colin (1991) Governmental Rationality: An Introduction. Pp. 1-48 in The
Foucault Effect: Studies in Ggovernmentality, edited by Graham Burchell, Colin
Gordon and Peter Miller. Chicago: University of Chicago Press.Gostin, Lawrence O. (2007) Mandatory HPV Vaccination: Public Health vs Private Wealth. The Journal of American Medical Association 297: 1921-1923.
Granovetter, Mark (1985) Economic Action and Social Structure: The Problem of Embeddedness. American Journal of Sociology 91: 481-510.
Green, Ken, Richard Hull, Andrew McMeekin and Vivien Walsh (1999) The
Construction of the Techno-Economic: Networks vs. Paradigms.” Research Policy 28: 777-792.
Hannoun, C. (1999) La Vaccination. Paris: Presses Universitaires de France.
Hardie, Iain and Donald MacKenzie (2007) Assembling an economic actor: the agencement of a Hedge Fund. The Sociological Review 55:57-80.
Hardt, Michael and Antonio Negri (2000) Empire. Cambridge, MA: Harvard University Press.
Hessel, Luc (2005) Risk management, vaccines and vaccination. Screening 04/2005:
18-20.
Hilleman, Maurice R. (2000) Vaccines in Historical Evolution and Perspective: a Narrative of Vaccine Discoveries. Vaccine 18: 1436-1447.
Hinman, Alan R. (2007) Book Review on State of Immunity., Journal of Clinical
Investigation 117: 1118.
Hooker, Claire and Alison Bashford (2002) Diphtheria and Australian Public Health:
Bacteriology and Its Complex Applications, c.1890-1930. Medical History 46(1):
41-64.
Hsu, Tzu-chiu, Lien-pin Chow, Huo-yao Wei, Chiung-lin Chen, Shu-tao Hsu, Chien-tao Huang, Masami Kitaoka and Hiroshi Sunaga (1971) A Controlled Field Trial for an Evaluation of Effectiveness of Mouse-brain Japanese Encephalitis Vaccine. JFMA 70: 55-61.
Illich, Ivan (1976) Medical nemesis. New York : Pantheon Books.
Institut Pasteur (1986) L’Institut Pasteur et L’Industrie. Lettre de L’Association Pour le
Développement de L’Institut Pasteur 20. Paris : Institut Pasteur.
Institute of Medicine (1985) Vaccine Supply and Innovation. Washington, D. C.:
National Academy Press.
Jacob, François (1970) La logique du vivant. Paris: Gallimard.
Jasanoff, Sheila (2004) Ordering Knowledge, Ordering Society. pp. 13-45 in States of
Knowledge, edited by Sheila Jasanoff. New York: Routledge.
Jessop, Bob (2011) Constituting another Foucault Effect: Foucault on States and Statecraft. pp. 56-73 in Governmentality: Current Issues and Future Challenges, edited by Ulrich Bröckling, Susanne Krasmann, and Thomas Lemke. New York:
Routledge.
Joerges, Bernward (1999) Do Politics Have Artefacts? Social Studies of Science 29(3):
411-431.
Kao, Jia- Horng and Chen Dinn-Shinn (2002) Global Control of Hepatitis B Virus Infection. Lancet Infectious Diseases 2: 395-403.
Karpik, Lucien (2000) Le Guide rouge Michelin. Sociologie du travail 42 :369-389.
Kervran, Roger (1962) Albert Calmette et le BCG. Paris: Hachette.
Kim, Jane J. (2011) The role of cost-effectiveness in U.S. vaccination policy. New
England Journal of Medicine 365: 1760-1761.
Klein, David L. and Ronald W. Ellis (1997) Conjugate vaccines against Streptococcus pneumoniae. Pp. 503-525 in New Generation Vaccines(2nd ed.), edited by M. M.
Levine et al. New York: Marcel Dekker, Inc.,.
Kremer, Michael (2001) “Creating Markets for New Vaccines. Pp. 35-118 in Innovation
Policy and the Economy, edited by Adam B. Jaffe, Josh Lerner and Scott Stern.
Cambridge, Mass.: MIT Press.
Latour, Bruno (1987) Science in Action. Milton Keynes: Open University Press.
—— (1996). Aramis, or the love of technology. Cambridge Mass.: Harvard University
Press.—— (2001) Pasteur: Guerre et paix des microbes. Paris: La Découverte
—— (2001) Pasteur: Guerre et Paix des Microbes. Paris: La Découverte.
Law, John and Annemarie Mol (1995) Notes on Materiality and Sociality. The
Sociological Review 43(2): 274-294.
Lemke, Thomas (2011) Biopolitics. New York: New York University Press.
Lepoutre, Agnès, Emmanuelle Varon, Scarlett Georges, Laurent Gutmann and Daniel Lévy-Bruhl, (2008). Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Eurosurveillance 13: 1-6.
Lindner, Ulrike and Stuart Blume (2006) Vaccine Innovation and Adoption: Polio Vaccines in the UK, the Netherlands and West Germany, 1955–1965. Medical
History 50: 425-446.
Lloyd, Adam et al. (2008) Cost-Effectiveness of Heptavalent Conjugate Pneumococcal Vaccine (Prevenar) in Germany. European Journal of Health Economics 9: 7-15.
Lopez, Rubens (2006) Pneumococcus: the sugarcoated bacteria. International
Microbiology 9: 179-190.
Lupton, Deborah (1995) The imperative of health: public health and regulated body.
London: Sage.
Maayan-Metzger, A., P. Kedem-Friedrich and J. Kuint (2005) To vaccinate or not to vaccinate – that is the question: why are some mothers opposed to giving their infants hapatitis B vaccine? Vaccine 23: 1941-1948.
MacKenzie, Donald (2006) An Engine, Not a Camera: How Financial Models Shape
Markets. Cambridge: Cambridge University Press.
MacKenzie, Donald and Yuval Millo (2003) Constructing a market, performing theory:
the historical sociology of a financial derivatives exchange. American journal of
sociology 109: 107-145.
Mahoney, James (2000) Path Dependence in Historical Sociology. Theory and Society 29(4):507–548.
Mahoney, Richard and J. E. Maynard (1999) The introduction of new vaccines into developing countries. Vaccine 17(7): 646-652.
Mahoney, Richard, Keun Lee and Mikyung Yun (2005) Intellectual property, drug regulation, and building product innovaton capability in biotechnology: the case of Hepatitis B vaccine in Korea. Innovation Strategy Today 1(2): 33-44.
McIntosh, Edwin D. G., Bernard Fritzell, Mark A. Fletcher (2007) Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiology and Infection 135:
644-656.
Moulin, Anne Marie (1991) Le Dernier Langage de la Médecine: Histoire de
L'immunologie de Pasteur au Sida. Paris: P.U.F.
—— (2006) Les Particularités Françaises de L'histoire de la Vaccination. La fin D'une
Exception ? Revue D'épidémiologie et de Santé Publique 54 HS1: 1S81-1S87.Mumford, Lewis (1970) The Myth of the Machine: the Pentagon of Power. New York:
Harcourt Brace Jovanovich.
Muniesa, Fabian, Yuval Millo and Michel Callon (2007) An Introduction to Market Devices. Pp. 1-12 in Market Devices, edited by Michel Callon, Yuval Millo and Fabian Muniesa. Oxford: Blackwell.
Munira, Syarifah Liza and Scott A. Fritzen (2007) What influences government adoption of new vaccines in developing countries? A policy process analysis. Social Science
and Medicine 65: 1751-1764.
Nadesan, Majia Holmer (2008) Governmentality, Biopower, and Everyday Life. New York: Routledge.
Nalin, David R. (2002) Evidence Based Vaccinology. Vaccine 20: 1624-1630.
Pauly, Mark, et al., eds. (1996) Supplying Vaccines: An Economic Analysis of Critical
Issues. Amsterdam: IOS Press.
Pinch, Trevor, and Wiebe E. Bijker (1987) The Social Construction of Facts and Artifacts:
Or How the Sociology of Science and the Sociology of Technology might Benefit Each Other. Pp. 17-50 in The Social Construction of Technological Systems, edited by Wiebe E. Bijker, Thomas P. Hughes and Trevor J. Pinch. Cambridge, MA: MIT Press.
Plotkin, Susan L. and Stanley A. Plotkin (1999) A Short History of Vaccination. Pp. 1-16 in Vaccines, edited by Stanley A. Plotkin and Walter A. Orenstein. Philadelphia, Pennsylvania: W.B. Saunders Company.
Podolny, Joel M. (2001) Networks as the Pipes and Prisms of the Market. American
Journal of Sociology 107: 33-60.
—— (2005) Status Signals: A Sociological Study of Market Competition. Princeton, NJ.:
Princeton University Press.
Polanyi, Karl (2001[1944]) The Great Transformation. Boston: Beacon.
Rabinow, Paul and Nicolas Rose (2006) Biopower Today. BioSocieties 1:195-217.
Raichvarg, Daniel (1995) Louis Pasteur: l’empire des microbes. Paris: Gallimard.
Rappuoli, Rino, Henry I. Miller and Stanley Falkow (2002) The Intangible Value of Vaccination. Science 297: 937-939.
Régis, Lachkar (2007) Enquête sur la pratique des vaccinations Prevenar® et contre
l’hépatite B, chez les nourrissons, en médecine générale. Unpublished dissertation
for Docteur en médecine, Université Paris Val-de-Marne.
Rose, Nikolas (2007) The Politics of Life Itself. Princeton: Princeton University Press.
Rose, Nikolas and Peter Miller (1992) Political Power Beyond the State: Problematics of Government. British Journal of Sociology 43(2):173-205.
Rose, Nikolas, Pat O’Malley and Mariana Valverde (2006) Governmentality. Annual
Review of Law and Social Science 2:83-104.
Santos, Ana C. and Joao Rodrigues (2009) Economics as social engineering? Questioning the performativity thesis. Cambridge Journal of Economics 33: 985-1000.
Schelling, Thomas (1960) Strategy of Conflict. Cambridge, MA: Harvard University Press.
Schrödinger, Erwin (1944) What is Life? Cambridge: Cambridge University Press.
Setbon, Michel, and Jocelyn Raude (2010) Factors in vaccination intention against the pandemic influenza A/H1N1. European Journal of Public Health 20(5): 490-494.
Sismondo, Sergio (2004) An Introduction to Science and Technology Studies. MA.:
Blackwell Publishing.
Streefland, P, A. M. R. Chowdhury and P. Ramos-Jimenez (1999) Patterns of vaccination acceptance. Social Science & Medicine, 49: 1705-1716.
Thacker, Eugene (2009) The Shadows of Atheology: Epidemics, Power and Life after Foucault. Theory, Culture & Society 26(6):135–153.
Thévenot, Laurent (2006) L’action au Pluriel. Paris: Editions La Découverte.
Van de Bulte, Christophe and Gary L. Lilien (2001) Medical Innovation Revisited: Social Contagion Versus Marketing Effect. American Journal of Sociology 106:
1409-1435.
Vandersmissen, Walter (2001) Business Perspectives of a European Vaccine Manufacturer.”Vaccine 20: S104-S106.
Veyne, Paul (2008) Foucault: sa pensée, sa personne. Paris : Albin Michel.
Watson, David A., Daniel M. Musher, James W. Jacobson and Jan Verhoef (1993) A brief history of the pneumococcus in biomedical research: a panoply of scientific
discovery. Clinical Infectious Diseases 17: 913-924.
White, Harrison (1981) Where do Markets Come From? American Journal of Sociology 87: 517-547.
Wilson, Christopher B. and Edgar K. Marcuse (2001) Vaccine Safety — Vaccine Benefits: Science and the Public’s Perception. Nature Reviews Immunology 1:
160-165.
Winner, Langdon (1980) Do Artifacts have Politics? Daedalus 109: 121-136.
—— (1986) Do Artifacts Have Politics? Pp. 19-39 in The Whale and the Reactor: A Search for Limits in an Age of High Technology, edited by Langdon Winner.
Chicago: University of Chicago Press.